Pathway for prescribing Sacubitril Valsartan (Entresto®)
Safe Prescribing and Use of Sacubitril Valsartan (Entresto) Infographic Infographics | Medicpresents.com
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial - ScienceDirect
FDA Advise-ERR: Concomitant use of Entresto and ACE inhibitors Can Lead to Serious Outcomes | Institute For Safe Medication Practices
Industry Sponsored Trials and Entresto in CHF - REBEL EM - Emergency Medicine Blog
JCM | Free Full-Text | Looking for a Tailored Therapy for Heart Failure: Are We Capable of Treating the Patient Instead of the Disease?
Top 7 Things to Know About Entresto - toplist.info
ACE Inhibitor-Induced Angioedema: a Review | SpringerLink
Is Entresto good for the brain?
Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure - ScienceDirect
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition | Circulation
Frontiers | Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
Herzinsuffizienz: Leitlinienempfehlung für Valsartan/Sacubitril
Treatment of Heart Failure | Washington Manual of Medical Therapeutics
Sacubitril/Valsartan: Where are we now? | BCS
Sacubitril/valsartan - Wikipedia
Herzinsuffizienz: Leitlinienempfehlung für Valsartan/Sacubitril
Frontiers | Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
Was es bei der Umstellung auf Sacubitril/Valsartan zu beachten gibt - 05 - 2016 - Heftarchiv - AMT
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan | Heart
